financetom
Business
financetom
/
Business
/
Builders FirstSource Profit Tops Forecasts Despite Weak Housing Market
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Builders FirstSource Profit Tops Forecasts Despite Weak Housing Market
Oct 30, 2025 12:29 PM

Builders FirstSource ( BLDR ) shares rose Thursday after the company reported better-than-expected third-quarter results that topped Wall Street estimates, but the stock has since given up its earlier gains.

The company posted quarterly adjusted earnings of $1.88 per share, exceeding Wall Street expectations of $1.64, though down 38.8% from a year earlier.

Revenue for the quarter came in at $3.94 billion, narrowly above analysts' forecast of $3.85 billion, but still 6.9% lower than the same quarter last year.

Also Read: What’s Going On With Builders FirstSource Stock Today?

Gross profit margin fell 240 basis points to 30.4%, weighed down by a below-normal housing starts environment. While adjusted EBITDA margin declined 380 basis points year over year to 11.0%, reflecting lower gross profit margins and reduced operating leverage.

Core organic sales down 10.6% year-over-year. Single-family sales fell 12.1%, multi-family dropped 20.2%, and repair and remodel/other declined 1.2%, mainly driven by lower housing starts and market demand.

By product category, value-added products such as manufactured components and windows, doors, and millwork declined 11.6% to $1.86 billion, while specialty building products and services rose 3.6% to $1.09 billion, partially offsetting declines in lumber and sheet goods, which was down 7.9%.

Builders FirstSource ( BLDR ) generated $547.7 million in operating cash and used $102.5 million in investing, resulting in free cash flow of $464.9 million, down from $634.7 million a year earlier on lower net income.

As of September 30, 2025, Builders FirstSource ( BLDR ) reported liquidity of about $2.1 billion, comprising $1.8 billion in net borrowing capacity under its revolving credit facility and $300 million in cash on hand.

Year-to-date, Builders FirstSource ( BLDR ) has repurchased 3.4 million shares of its common stock at an average price of $118.65 per share, for a total of $403.6 million, including fees and taxes.

Since initiating its share repurchase program in August 2021, the company has repurchased 99.3 million shares, or 48.1% of its total outstanding stock, at an average price of $80.90 per share, for a total cost of $8.0 billion, inclusive of fees and taxes.

Year to date, the company has achieved about $33 million in productivity savings and expects to generate an additional $45 million to $60 million in savings for full-year 2025.

Outlook

Builders FirstSource ( BLDR ) expects full-year 2025 sales between $15.1 billion and $15.4 billion, compared with analysts' estimate of $15.30 billion.

The company also expects its gross profit margin to range between 30.1% and 30.5%, and adjusted EBITDA margin to range between 10.6% and 11.1% for the full year.

CEO Commentary

Peter Jackson, CEO of Builders FirstSource ( BLDR ), commented, “Our third quarter results reflect the strength of our strategy and disciplined execution in a weak housing market. Over the past several years, we have transformed into a stronger organization powered by our leading network of value-added solutions, a relentless focus on operational excellence, and capital deployment.”

Price Action: BLDR shares were trading higher by 2.94% to $111.90 at last check Thursday.

Read Next:

Why Is Shake Shack Stock Gaining Today?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug
Biogen Partner Eisai Submits FDA Biologics Application for Early Alzheimer's Self-Injection Drug
May 15, 2024
04:26 AM EDT, 05/15/2024 (MT Newswires) -- Biogen (BIIB) and Eisai said Tuesday that the latter has initiated a rolling submission of a biologics license application to the US Food and Drug Administration for lecanemab-irmb subcutaneous autoinjector as a weekly maintenance treatment for early Alzheimer's disease. The application came after the treatment, commercially known as Leqembi, was granted FDA fast-track...
Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket
Update: Arcutis Biotherapeutics Q1 Loss Narrows as Revenue Surges; Shares Soar Premarket
May 15, 2024
04:24 AM EDT, 05/15/2024 (MT Newswires) -- (Updates with the stock move in the headline and the first paragraph.) Arcutis Biotherapeutics' ( ARQT ) shares surged more than 20% in premarket activity on Wednesday after the company reported a narrower loss and handily beat market expectations for sales. The company reported a Q1 loss late Tuesday of $0.32 per diluted...
Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo
Novonix Signs Testing, Development Deal With Volkswagen-Owned PowerCo
May 15, 2024
04:32 AM EDT, 05/15/2024 (MT Newswires) -- Novonix ( NVX ) said late Tuesday it signed a non-exclusive testing and development agreement with Volkswagen-owned PowerCo to come up with synthetic graphite anode materials for electric vehicle batteries. The companies could later enter into a supply agreement for the products developed under the deal, Novonix ( NVX ) said. Financial terms...
New York Community Bancorp to Sell $5 Billion in Mortgage Warehouse Loans to JPMorgan Chase Bank
New York Community Bancorp to Sell $5 Billion in Mortgage Warehouse Loans to JPMorgan Chase Bank
May 15, 2024
04:12 AM EDT, 05/15/2024 (MT Newswires) -- New York Community Bancorp ( NYCB/PU ) said Tuesday it has entered into a commitment letter to sell about $5 billion in mortgage warehouse loans to JPMorgan Chase Bank. The sale is expected to close in Q3. Shares of New York Community Bancorp gained almost 6% in after-market hours on Tuesday. Price: 4.1200,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved